Cannabis Science, Inc., (OTC: CBIS) a U.S. company specializing in the development of cannabinoid-based medicines, has entered into an expanded 5-year, $1.8 million Research Collaboration Agreement (RCA) with Dana Farber Cancer Institute, Inc., encompassing operating procedures and related ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment